A monoclonal antibody against human complement component C3: the production of C3 by human cells in vitro.

A monoclonal antibody against human complement component C3: the production of C3 by human cells in vitro.

A monoclonal antibody (WM1) against the third component of human complement (C3) was produced by fusing P3-X63-Ag8 mouse myeloma cells with spleen cells from BALB/c mice immunized with purified C3. The specificity of WM1 antibody against C3 was established by its capacity to inhibit a standard C3 he...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Whitehead, A, Sim, R, Bodmer, W
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	1981

Παρόμοια τεκμήρια

MONOCLONAL-ANTIBODIES AGAINST HUMAN C-3
ανά: Whitehead, A, κ.ά.
Έκδοση: (1980)

PRODUCTION OF MONOCLONAL ANTIBODY AGAINST HUMAN IMMUNOGLOBULIN
ανά: J. Majidi, κ.ά.
Έκδοση: (2000-04-01)

Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis
ανά: Lin-Lin Li, κ.ά.
Έκδοση: (2019-12-01)

The first component of human complement
ανά: Sim, R
Έκδοση: (1976)

C3 and C4 complement components in autoimmune hepatitis.
ανά: Eman Sh. AL-Obeidy, κ.ά.
Έκδοση: (2007-10-01)

Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species
ανά: Wioleta M. Zelek, κ.ά.
Έκδοση: (2020-12-01)

A MONOCLONAL-ANTIBODY TO SPECIFIC HUMAN EPIDERMAL-CELL LAYERS
ανά: Goldsmith, L, κ.ά.
Έκδοση: (1980)

Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2.
ανά: Parham, P, κ.ά.
Έκδοση: (1978)

Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer
ανά: Kiefer Hans, κ.ά.
Έκδοση: (2009-06-01)

Human complement component C3 N-glycome changes in type 1 diabetes complications
ανά: Dinko Šoić, κ.ά.
Έκδοση: (2023-05-01)

Conversion of the C3 component of complement in sera of hanseniasis patients
ανά: Teresa A. E. Kliemann, κ.ά.
Έκδοση: (1983-06-01)

Intramolecular general acid catalysis in the binding reactions of alpha 2-macroglobulin and complement components C3 and C4.
ανά: Davies, S, κ.ά.
Έκδοση: (1981)

Monoclonal Antibody Production against Human Spermatozoal Surface Antigens
ανά: M Jedi-Tehrani, κ.ά.
Έκδοση: (2005-10-01)

The gene structure and the polymorphism of the human complement component C4
ανά: Yu, C, κ.ά.
Έκδοση: (1987)

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy
ανά: Sophie Chauvet, κ.ά.
Έκδοση: (2018-10-01)

Evaluation of complement components C3 and C4 in serum of patient with neoplastic diseases
ανά: Zeenah weheed Atwan, κ.ά.
Έκδοση: (2019-06-01)

Evaluation of complement components C3 and C4 in serum of patient with neoplastic diseases
ανά: Zeenah weheed Atwan, κ.ά.
Έκδοση: (2019-06-01)

Evaluation of complement components C3 and C4 in serum of patient with neoplastic diseases
ανά: Zeenah weheed Atwan, κ.ά.
Έκδοση: (2019-06-01)

4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis
ανά: Jérôme Granel, κ.ά.
Έκδοση: (2020-09-01)

Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
ανά: Bindon, C, κ.ά.
Έκδοση: (1988)

Downhill running does not alter blood C1q availability or complement-dependent cytotoxicity of therapeutic monoclonal antibodies against haematological cancer cell lines in vitro
ανά: Harrison D. Collier-Bain, κ.ά.
Έκδοση: (2024-11-01)

Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement.
ανά: Ezekowitz, R, κ.ά.
Έκδοση: (1985)

Estimation of Complement Components (C3 and C4) and hs-CRP Level in Kidney Failure Patients
ανά: Zaid N. Elia, κ.ά.
Έκδοση: (2019-12-01)

Monoclonal antibodies effectively potentiate complement activation and phagocytosis of Staphylococcus epidermidis in neonatal human plasma
ανά: Lisanne de Vor, κ.ά.
Έκδοση: (2022-07-01)

Allele frequencies of the third component of complement (C3) in MS patients.
ανά: Bulman, D, κ.ά.
Έκδοση: (1991)

Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody
ανά: Leon Cyranka, κ.ά.
Έκδοση: (2023-11-01)

Production and Characterization of Monoclonal Antibodies Against the Dimerization Domain of Human HER2
ανά: Nadri, κ.ά.
Έκδοση: (2015-07-01)

Complement Component C3 Binds to the A3 Domain of von Willebrand Factor
ανά: Jennifer G. Nolasco, κ.ά.
Έκδοση: (2018-07-01)

Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines
ανά: Sára Kellnerová, κ.ά.
Έκδοση: (2020-12-01)

Investigation of complement component C4 copy number variation in human longevity.
ανά: Friederike Flachsbart, κ.ά.
Έκδοση: (2014-01-01)

Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm
ανά: Lisanne de Vor, κ.ά.
Έκδοση: (2022-01-01)

Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.
ανά: Parham, P, κ.ά.
Έκδοση: (1979)

Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1
ανά: Elena Boero, κ.ά.
Έκδοση: (2023-01-01)

Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality
ανά: Nicolas Aubrey, κ.ά.
Έκδοση: (2022-08-01)

Monoclonal antibody targeting complement C9 binding domain of Trichinella spiralis paramyosin impairs the viability of Trichinella infective larvae in the presence of complement
ανά: Yuwan Hao, κ.ά.
Έκδοση: (2014-07-01)

P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS
ανά: A. Wiestner, κ.ά.
Έκδοση: (2022-06-01)

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.
ανά: Hale, G, κ.ά.
Έκδοση: (1983)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
ανά: Cobbold, S, κ.ά.
Έκδοση: (1990)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
ανά: Cobbold, S, κ.ά.
Έκδοση: (1990)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
ανά: Wang, LT
Έκδοση: (2022)